Jointown(SH:600998) Ge Long Hui A P P·2025-10-16 10:10Core Viewpoint - The approval of the drug "Gelong Bromide" by the National Medical Products Administration marks a significant milestone for the company, indicating potential growth in the pharmaceutical market [1] Company Summary - The company, Jiuzhoutong, announced that its subsidiary, Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd., received the approval for the listing application of Gelong Bromide on October 16, 2025 [1] - Gelong Bromide is a quaternary ammonium anticholinergic drug that selectively acts on the digestive tract, inhibiting gastric secretion and adjusting gastrointestinal motility [1] Product Summary - Gelong Bromide can be used for treating gastric and duodenal ulcers, chronic gastritis, and as a maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults, including chronic bronchitis and emphysema [1] - The drug works by specifically binding to and inhibiting the M3 acetylcholine receptors distributed in bronchial smooth muscle, leading to airway dilation [1]